Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use Elitek safely and effectively. See full prescribing information for Elitek®. ELITEK (rasburicase) for injection, for intravenous useInitial U.S. Approval: 2002
Medication labelWhy this: Advisory · dailymed-prescription
Elitek is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anticancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid. Limitations of Use Elitek is indicated only for a single course of treatment [see Warnings and Precautions (5.1)] .
- generic_name
- rasburicase
- brand_name
- Diluent
- product_names
- rasburicase, Diluent
- ndc
- 0024-5150, 0024-5151, 0024-5155, 0024-5150-10, 0024-5154, 0024-5154-11, 0024-5152, 0024-5152-11, 0024-5151-75, 0024-5155-74, 0024-5153, 0024-5153-74
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en